• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Colchicine for cardiovascular prevention: the dawn of a new era has finally come.

作者信息

Bonaventura Aldo, Abbate Antonio

机构信息

Department of Internal Medicine, S.C. Medicina Generale 1, Medical Center, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, Varese, Italy.

Division of Cardiovascular Medicine, Department of Medicine, Robert M. Berne Cardiovascular Research Center, University of Virginia, 415 Lane Rd (MR5), PO Box 801394, Charlottesville, VA 22903, USA.

出版信息

Eur Heart J. 2023 Sep 14;44(35):3303-3304. doi: 10.1093/eurheartj/ehad453.

DOI:10.1093/eurheartj/ehad453
PMID:37528664
Abstract
摘要

相似文献

1
Colchicine for cardiovascular prevention: the dawn of a new era has finally come.用于心血管疾病预防的秋水仙碱：新时代终于来临。
Eur Heart J. 2023 Sep 14;44(35):3303-3304. doi: 10.1093/eurheartj/ehad453.
2
Colchicine for the treatment of cardiovascular diseases: old drug, new targets.用于治疗心血管疾病的秋水仙碱：旧药，新靶点。
J Cardiovasc Med (Hagerstown). 2021 Jan;22(1):1-8. doi: 10.2459/JCM.0000000000001079.
3
[Colchicine treatment after myocardial infarction : Colchicine Cardiovascular Outcomes Trial (COLCOT)].心肌梗死后的秋水仙碱治疗：秋水仙碱心血管结局试验（COLCOT）
Internist (Berl). 2020 Jul;61(7):766-769. doi: 10.1007/s00108-020-00768-2.
4
Colchicine Use in Acute Coronary Syndromes: An Update.秋水仙碱在急性冠状动脉综合征中的应用：最新进展
Angiology. 2021 Jul;72(6):503-510. doi: 10.1177/0003319720985644. Epub 2021 Jan 8.
5
Repurposing Colchicine for Heart Disease.将秋水仙碱用于治疗心脏病（药物用途拓展）
Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:121-129. doi: 10.1146/annurev-pharmtox-052120-020445. Epub 2021 Sep 30.
6
Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis.秋水仙碱用于冠心病二级预防的疗效和安全性：系统评价和荟萃分析。
Intern Emerg Med. 2021 Mar;16(2):487-496. doi: 10.1007/s11739-020-02606-7. Epub 2021 Jan 5.
7
Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication?炎症可能是未来心血管风险降低的方向：秋水仙碱是否有当前的适应证？
Am J Cardiovasc Drugs. 2021 Jan;21(1):1-10. doi: 10.1007/s40256-020-00408-y.
8
Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.为什么秋水仙碱应该被考虑用于动脉粥样硬化的二级预防：概述。
Clin Ther. 2019 Jan;41(1):41-48. doi: 10.1016/j.clinthera.2018.11.016. Epub 2018 Dec 24.
9
Colchicine for cardiovascular medicine: a systematic review and meta-analysis.秋水仙碱在心血管医学中的应用：系统评价和荟萃分析。
Future Cardiol. 2022 Aug;18(8):647-659. doi: 10.2217/fca-2020-0206. Epub 2022 Jul 5.
10
The cardiovascular effects of colchicine: a comprehensive review.秋水仙碱的心血管效应：一项全面综述。
Cardiol Rev. 2015 Nov-Dec;23(6):317-22. doi: 10.1097/CRD.0000000000000056.

引用本文的文献

1
IL6 genetic perturbation mimicking IL-6 inhibition is associated with lower cardiometabolic risk.模仿白细胞介素-6抑制的白细胞介素-6基因干扰与较低的心脏代谢风险相关。
Nat Cardiovasc Res. 2025 Aug 26. doi: 10.1038/s44161-025-00700-7.
2
The impact of immune checkpoint inhibition on atherosclerosis in cancer patients.免疫检查点抑制对癌症患者动脉粥样硬化的影响。
Front Immunol. 2025 Jul 31;16:1604989. doi: 10.3389/fimmu.2025.1604989. eCollection 2025.
3
Dysfunction of Microcirculation in Atherosclerosis: Implications of Nitric Oxide, Oxidative Stress, and Inflammation.
动脉粥样硬化中的微循环功能障碍：一氧化氮、氧化应激和炎症的影响
Int J Mol Sci. 2025 Jul 4;26(13):6467. doi: 10.3390/ijms26136467.
4
Inflammation resolution-based treatment of atherosclerosis using biomimetic nanocarriers loaded with specialized pro-resolving lipid mediators.使用负载有特殊促消退脂质介质的仿生纳米载体基于炎症消退的动脉粥样硬化治疗。
Mater Today Bio. 2025 Apr 5;32:101733. doi: 10.1016/j.mtbio.2025.101733. eCollection 2025 Jun.
5
The Emerging Role of Colchicine to Inhibit NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome and Interleukin-1β Expression in In Vitro Models.秋水仙碱在体外模型中抑制含吡喃结构域的NOD样受体家族3炎性小体及白细胞介素-1β表达的新作用
Biomolecules. 2025 Mar 3;15(3):367. doi: 10.3390/biom15030367.
6
Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies.糖尿病驱动的动脉粥样硬化：最新机制见解与新型治疗策略
Int J Mol Sci. 2025 Feb 28;26(5):2196. doi: 10.3390/ijms26052196.
7
The Effect of Colchicine on Platelet Function Profiles in Patients with Stable Coronary Artery Disease: The ECLIPSE Pilot Study.秋水仙碱对稳定型冠状动脉疾病患者血小板功能谱的影响：日蚀试点研究
Cardiol Ther. 2025 Mar;14(1):87-100. doi: 10.1007/s40119-024-00393-2. Epub 2025 Jan 18.
8
Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches.糖尿病中的动脉粥样硬化：新机制及基于机制的治疗方法。
Nat Rev Cardiol. 2025 Jan 13. doi: 10.1038/s41569-024-01115-w.
9
The association between energy-adjusted dietary inflammatory index and 10-year cardiovascular risk: Fasa adult cohort study.能量调整膳食炎症指数与10年心血管疾病风险之间的关联：法萨成人队列研究。
Food Sci Nutr. 2024 May 13;12(8):5530-5537. doi: 10.1002/fsn3.4181. eCollection 2024 Aug.
10
Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease.血管炎症和动脉粥样硬化性心血管疾病中的特异性促解决介质。
Nat Rev Cardiol. 2024 Nov;21(11):808-823. doi: 10.1038/s41569-023-00984-x. Epub 2024 Jan 12.